FDA ad­comm votes 12-1 against Le­vo Ther­a­peu­tic­s' nasal spray for a dis­or­der that caus­es in­sa­tiable hunger

The FDA’s Psy­chophar­ma­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee on Thurs­day vot­ed 12 to 1 against ap­prov­ing Le­vo Ther­a­peu­tics’ nasal spray for Prad­er-Willi syn­drome, a dif­fi­cult-to-treat dis­ease that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER